Please login to the form below

Not currently logged in
Email:
Password:

report

This page shows the latest report news and features for those working in and with pharma, biotech and healthcare.

Novartis makes case for gene therapy Zolgensma in SMA

Novartis makes case for gene therapy Zolgensma in SMA

It also called for Zolgensma to be priced somewhere between $900, 000 and $1.5m, however Novartis hit back at the report, saying that the cost-effective estimates are “designed around

Latest news

More from news
Approximately 25 fully matching, plus 2,127 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 235 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 148 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 5 fully matching, plus 248 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics